A new link in ovarian cancer angiogenesis: Lysophosphatidic acid and vascular endothelial growth factor expression

Journal of the National Cancer Institute

Volumn 93, Issue 10, 2001, Pages 734-735

  Folkman, J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; BCR ABL PROTEIN; CELL RECEPTOR; CETUXIMAB; GROWTH FACTOR RECEPTOR; IMATINIB; INTERLEUKIN 8; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN C FOS; PROTEIN C JUN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE; TRASTUZUMAB; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ASCITES FLUID; CANCER CELL; CANCER RECURRENCE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CLASSIFICATION; DRUG MECHANISM; DRUG TARGETING; EDITORIAL; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; LONG TERM CARE; MOUSE; NONHUMAN; ONCOGENE NEU; OVARY CANCER; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING;

EID: 0035897501     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.10.734     Document Type: Editorial

References (13)

1. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
2. Oncogenes and angiogenesis: Signaling three-dimensional tumor growth
3. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
4. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
5. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
6. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells
7. Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis
8. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization
9. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
10. Blockade of PDGF-R signaling by STI571 inhibits angiogenesis and growth of human prostate cancer cells in the bone of nude mice
11. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
12. Inhibition of tumor angiogenesis as a strategy to circumvent resistance to anti-cancer therapeutic agents
13. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance